TOP TIERMARKET NEWSWIRE
SEC Form 4 history

BRAVEHEART BIO INC (BRVE) insider trades

BRAVEHEART BIO INC (BRVE) insider trading activity (SEC Form 4). Over the trailing 90 days, BRVE insiders filed 10 purchases totalling $159.0M and 0 sales totalling $0 — net BUYING of $159.0M. Most recent filing: Aug 11, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
10
$159.0M
Sells (90d)
0
$0
Net (90d)
+$159.0M
net buying
Most recent
Aug 11, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Aug 11, 2026Ah Bio Fund Iv, L.P.10%P Purchase—$18.00$19.8Mfiling
Aug 11, 2026Chimovits ErezDir, 10%P Purchase—$18.00$34.9Mfiling
Aug 11, 2026Orbimed Advisors LLCDir, 10%P Purchase—$18.00$34.9Mfiling
Aug 7, 2026Forbion Growth Opportunities Fund III Cooperatief U.A.10%P Purchase—$18.00$64.8Mfiling
Aug 7, 2026Rickey James PaulCFOP Purchase—$18.00$500Kfiling
Aug 7, 2026Lubner David CharlesDirP Purchase—$18.00$1000Kfiling
Aug 7, 2026Murdoch TravisCEO, PresP Purchase—$18.00$1.5Mfiling
Aug 7, 2026Anderson Michele A.Chief Development OfficerP Purchase—$18.00$20Kfiling
Aug 7, 2026Malek David IDirP Purchase—$18.00$75Kfiling
Aug 7, 2026Viehbacher ChristopherDirP Purchase—$18.00$1.5Mfiling